ArticleJPRAS open2026
Targeted LVA guided by ultra-high frequency ultrasound and ICG lymphography: A pilot study.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Breast cancer-related lymphedema (BCRL) is a chronic sequela that significantly impairs quality of life. Lymphovenous anastomosis (LVA) is a promising microsurgical treatment, but its success relies on accurate identification of functional lymphatic vessels and adjacent venules. While indocyanine green lymphography (ICG-L) provides functional lymphatic mapping, venous visualization is often limited. Ultra-high frequency ultrasound (UHFUS), offering high-resolution imaging, may complement ICG-L in preoperative planning. This feasibility study investigated the combined use of ICG-L and UHFUS for vessel identification prior to LVA. Method: Ten female patients with BCRL were included. Preoperative mapping combined ICG-L for lymphatics and UHFUS (45-70 MHz) for venules before LVA surgery. The primary outcome was agreement between preoperatively identified and intraoperatively confirmed lymphatic and venous vessels, as well as between planned and performed anastomoses. Secondary outcomes included changes in arm volume, quality of life, and L-Dex scores over 12 months. Results: Preoperative mapping identified a median of two lymphatic and two venous vessels per patient, leading to a median of two planned anastomoses. Intraoperative findings confirmed most vessels, with a median of two anastomoses performed per patient (p = 0.65). Arm volume did not decrease significantly over the 12 months. Quality-of-life and L-Dex scores showed a trend towards improvement. Conclusion: Combining UHFUS with ICG-L for preoperative planning of LVA is feasible and enables accurate identification of suitable lymphatic and venous vessels. Although no significant reduction in arm volume was observed, improvements in quality of life and L-Dex scores suggest a possible clinical benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.